Chemistry:Baxdrostat
From HandWiki
Short description: Chemical compound
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C22H25N3O2 |
| Molar mass | 363.461 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Baxdrostat is an investigational drug that is being evaluated for the treatment of hypertension.[1] It is an aldosterone synthase inhibitor.[2][3]
Refences
- ↑ "Baxdrostat - CinCor Pharma". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800054826.
- ↑ "Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension". Current Problems in Cardiology 48 (11): 101918. July 2023. doi:10.1016/j.cpcardiol.2023.101918. PMID 37399857.
- ↑ "Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension". Expert Opinion on Investigational Drugs: 1–11. October 2023. doi:10.1080/13543784.2023.2276755. PMID 37883217.
